Cargando…

Pharmacogenetically Guided Escitalopram Treatment for Pediatric Anxiety Disorders: Protocol for a Double-Blind Randomized Trial

Current pharmacologic treatments for pediatric anxiety disorders (e.g., selective serotonin reuptake inhibitors (SSRIs)) frequently use “one size fits all” dosing strategies based on average responses in clinical trials. However, for some SSRIs, including escitalopram, variation in CYP2C19 activity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Strawn, Jeffrey R., Poweleit, Ethan A., Mills, Jeffrey A., Schroeder, Heidi K., Neptune, Zoe A., Specht, Ashley M., Farrow, Jenni E., Zhang, Xue, Martin, Lisa J., Ramsey, Laura B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621124/ https://www.ncbi.nlm.nih.gov/pubmed/34834540 http://dx.doi.org/10.3390/jpm11111188

Ejemplares similares

Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders
por: Aldrich, Stacey L., et al.
Publicado: (2019)

The Impact of COVID-19 Infection and Characterization of Long COVID in Adolescents With Anxiety Disorders: A Prospective Longitudinal Study
por: Strawn, Jeffrey R., et al.
Publicado: (2023)

Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents
por: Strawn, Jeffrey R., et al.
Publicado: (2023)

Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors
por: Strawn, Jeffrey R., et al.
Publicado: (2021)

The Impact of Marijuana on Antidepressant Treatment in Adolescents: Clinical and Pharmacologic Considerations
por: Vaughn, Samuel E., et al.
Publicado: (2021)

Selective Serotonin Reuptake Inhibitor Pharmacokinetics During Pregnancy: Clinical and Research Implications
por: Poweleit, Ethan A., et al.
Publicado: (2022)

Pediatric anxiety and daily fine particulate matter: A longitudinal study
por: Vancil, Andrew, et al.
Publicado: (2022)

Resistant social anxiety disorder response to Escitalopram
por: Pallanti, Stefano, et al.
Publicado: (2006)

Celecoxib pharmacogenetics and pediatric adenotonsillectomy: a double-blinded randomized controlled study
por: Murto, Kimmo, et al.
Publicado: (2015)

Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled trial
por: Alaka, Karla J, et al.
Publicado: (2014)

Protocol for Escitalopram and Language Intervention for Subacute Aphasia (ELISA): A randomized, double blind, placebo-controlled trial
por: Stockbridge, Melissa D., et al.
Publicado: (2021)

Escitalopram in patients with psoriasis
por: Artemieva, M., et al.
Publicado: (2021)

The treatment of generalized anxiety disorder with pregabalin, an atypical anxiolytic
por: Strawn, Jeffrey R, et al.
Publicado: (2007)

A Randomized, Double-Blind, Placebo-Controlled Trial of Vilazodone in Children and Adolescents with Major Depressive Disorder with Twenty-Six-Week Open-Label Follow-Up
por: Findling, Robert L., et al.
Publicado: (2020)

Double blind, randomised trial to compare efficacy of escitalopram versus citalopram for interferon induced depression in hepatitis C patients
por: Shakeel, Uzma, et al.
Publicado: (2020)

Long-term administration of escitalopram in patients with social anxiety disorder in Japan
por: Asakura, Satoshi, et al.
Publicado: (2016)

Escitalopram Versus Citalopram and Sertraline: A Double-Blind Controlled, Multi-centric Trial in Indian Patients with Unipolar Major Depression
por: Lalit, Vaya, et al.
Publicado: (2004)

Efficacy and safety of generic escitalopram versus Lexapro in the treatment of major depression: a multicenter double-blinded randomized controlled trial
por: Yu, Yimin, et al.
Publicado: (2013)

Escitalopram induced mania
por: Parker, Shubangi, et al.
Publicado: (2007)

Escitalopram Induced Angioedema
por: Conde, Samantha L, et al.
Publicado: (2022)

Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD)
por: Hansen, Baiba Hedegaard, et al.
Publicado: (2009)

Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects
por: Becker, Anna M., et al.
Publicado: (2021)

Chronic escitalopram in healthy volunteers has specific effects on reinforcement sensitivity: a double-blind, placebo-controlled semi-randomised study
por: Langley, Christelle, et al.
Publicado: (2023)

Pharmacogenetics of SSRIs and Sexual Dysfunction
por: Osis, Liana, et al.
Publicado: (2010)

Sertraline versus escitalopram in South Asians with moderate to severe major depressive disorder: (SOUTH-DEP) a double-blind, parallel, randomized controlled trial
por: Raza, Sidra, et al.
Publicado: (2023)

An Open-Label Rater-Blinded Randomized Trial of Vilazodone versus Escitalopram in Major Depression
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2022)

Safety and effectiveness of escitalopram in an 8-week open study in Chinese patients with depression and anxiety
por: Wang, Gang, et al.
Publicado: (2018)

Effects of Escitalopram on Anxiety in Patients with Acute Coronary Syndrome: A Randomized Controlled Trial
por: Kang, Hee-Ju, et al.
Publicado: (2017)

Efficacy and safety of generic escitalopram (Lexacure(®)) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram-comparative, non-inferiority study
por: Jeong, Jong-Hyun, et al.
Publicado: (2015)

Reproducibility of the Efficacy of Escitalopram in Patients with Major Depression Who Had Previously Remitted with Escitalopram
por: Yoshimura, Reiji, et al.
Publicado: (2021)

The Effect of Escitalopram on Central Serotonergic and Dopaminergic Systems in Patients with Cervical Dystonia, and Its Relationship with Clinical Treatment Effects: A Double-Blind Placebo-Controlled Trial
por: Zoons, Evelien, et al.
Publicado: (2020)

Intramuscular ketamine vs. escitalopram and aripiprazole in acute and maintenance treatment of patients with treatment-resistant depression: A randomized double-blind clinical trial
por: Cigognini, Marco Aurélio, et al.
Publicado: (2022)

Interaction between escitalopram and risperidone
por: Rao, Pradeep, et al.
Publicado: (2005)

Severe hyponatremia associated with escitalopram
por: Rawal, Gautam, et al.
Publicado: (2017)

Escitalopram-induced extrapyramidal symptoms
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2019)

Rise of escitalopram and the fall of citalopram
por: Cavanah, Luke R., et al.
Publicado: (2023)

Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial
por: Pérez, Víctor, et al.
Publicado: (2017)

Escitalopram-induced epistaxis: A case report
por: AlJhani, Sumayah A.
Publicado: (2021)

A Double-Blind Randomized Trial to Investigate Mechanisms of Antidepressant-Related Dysfunctional Arousal in Depressed or Anxious Youth at Familial Risk for Bipolar Disorder
por: Honeycutt, Duncan C., et al.
Publicado: (2022)

Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicentre, randomised, double-blind, placebo-controlled trial
por: Otte, Christian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o46pg5fvtgjsrt7mqjbi982ag9